Dermira to Present Data for DRM01 Acne Program at 45th Annual ESDR Meeting – MarketWatch

Dermira to Present Data for DRM01 Acne Program at 45th Annual ESDR MeetingMarketWatch… In Phase 3 development in collaboration with UCB Pharma S.A. For the treatment of moderate-to-severe plaque psoriasis; DRM04, in Phase 3 development for the treatment of axillary hyperhidrosis; and DRM01, in Phase 2b development for the treatment …and more »

[monetize id=”1″]
[monetize id=”2″]

Multiple Autoimmune Diseases Share Same Genetic Risk Factors – Medscape

Multiple Autoimmune Diseases Share Same Genetic Risk FactorsMedscapeThe 10 clinically distinct pAIDs included in the analysis were type 1 diabetes, celiac disease, juvenile idiopathic arthritis, common variable immunodeficiency disease, systemic lupus erythematosus, Crohn's disease, ulcerative colitis, psoriasis …and more »

https://www.dpsw.org/what-is-psorasis